Top Story

A visual abstract of the study.
Molecular Imaging
PET/MRI can reduce the need for biopsies in prostate cancer
Prostate biopsies are associated with considerable morbidity, including pain, rectal bleeding, prostatitis, and urinary tract infections.
Featured
The Safe Hearts Plan aims to shift healthcare systems toward prevention, earlier diagnosis, and more personalized care.
CT
Imaging takes center stage in Europe's Safe Hearts Plan
Dr. Aart J. van der Molen, of Leiden University Medical Center in Leiden, the Netherlands, is the lead author of a review exploring side-chain chemistry as a guide for selecting alternative iodine-based contrast media.
CT
Can side-chain chemistry help radiologists choose a safer contrast agent after a hypersensitivity reaction?
Latest News
Patient Cancer Doctor 400 (1)
Most patients want to know if AI being used for imaging reports
June 30, 2026
An example of machine learning–based multiorgan body composition assessment (TotalSegmentator V2.0.4, 1.5-mm high-resolution model) in a 63-year-old man with obstructive coronary artery disease and a skeletal muscle attenuation below the median. (A) Transverse, (B) coronal, and (C) sagittal CT images and curved planar reformations of the (D) left, (E) circumflex, and (F) right coronary arteries.
Low muscle density on coronary CT linked to heart risk
June 30, 2026
AI adoption is growing across UK imaging and cancer services, but workforce shortages persist-
More work than relief: AI in the wrong seat, RCR census finds
June 29, 2026
The 2025 census report from the Royal College of Radiologists highlights the challenges facing services across the UK.
U.K. radiologist staffing lags EU peers, RCR census shows
June 25, 2026
Cases of the Week
Check out our Cases of the Week!
26-year-old man with multiple gunshot wounds and abdominal trauma - revisited
A 26-year-old man was brought to the emergency department after sustaining multiple gunshot wounds and blunt trauma to the abdomen.
77-year-old woman with abdominal pain revisited
40-year-old man undergoing x-ray after placement of pacemaker
View All Cases
A visual abstract of the study.
Molecular Imaging
PET/MRI can reduce the need for biopsies in prostate cancer
CT
Imaging takes center stage in Europe's Safe Hearts Plan
Editor's Note
AuntMinnieEurope.com CT Insider
CT
Can side-chain chemistry help radiologists choose a safer contrast agent after a hypersensitivity reaction?
CT
Low muscle density on coronary CT linked to heart risk
Patient Cancer Doctor 400 (1)
AI
Most patients want to know if AI being used for imaging reports
AI
More work than relief: AI in the wrong seat, RCR census finds
AI
One tool, many rulebooks: How the world is and isn't regulating medical AI
AI
The great AI debate: Expensive failure or vital prerequisite?
MRI
AI gives a boost to cardiac MRI risk prediction
Qp Breast Press 02
Womens Imaging
Quibim launches AI breast MRI tool across Europe, UK
Molecular Imaging
GE HealthCare, University Hospital Essen open nuclear medicine center
CT
Medneo acquires Ramsay Diagnostics UK mobile imaging fleet
Nuclear Medicine
Ratio Therapeutics signs Ac-225 supply agreement with PanTera
Industry News
GE HealthCare offers upgrades for interventional systems
More from AuntMinnieEurope
Quibim launches AI breast MRI tool across Europe, UK
By AuntMinnieEurope.com staff writers
The tool, QP-Breast, highlights suspicious areas on MRI and generates reports from imaging findings.
July 2, 2026
Qp Breast Press 02
GE HealthCare, University Hospital Essen open nuclear medicine center
By AuntMinnieEurope.com staff writers
The center features the first installation of GE HealthCare's StarGuide GX SPECT/CT scanner.
July 1, 2026
Ge
Medneo acquires Ramsay Diagnostics UK mobile imaging fleet
By AuntMinnieEurope.com staff writers
Medneo is acquiring Ramsay Diagnostics UK's mobile MRI and CT fleet and a six-year contract to provide mobile imaging services.
June 30, 2026
Mri Scanner2 400
Ratio Therapeutics signs Ac-225 supply agreement with PanTera
By AuntMinnie.com staff writers
Deal will support Ratio's alpha therapy programs.
June 30, 2026
Business Deal Corporate 400
GE HealthCare offers upgrades for interventional systems
By AuntMinnie.com staff writers
Upgraded systems also qualify for GE HealthCare's Tube Watch and OnWatch Predict service options.
June 29, 2026
Ai Logo
Fujifilm, IAEA sign agreement to expand cancer imaging
By AuntMinnie.com staff writers
The two organizations will collaborate on awareness campaigns, education and training programs for healthcare professionals, and the provision of Fujifilm medical equipment.
June 29, 2026
Acquisitions
Canon Medical, Fraiya partner for AI prenatal ultrasound in Europe
By AuntMinnieEurope.com staff writers
Imaging focuses on the mid-trimester anomaly scan.
June 26, 2026
Image2
Novel SST2-PET tracer shows promise in patients with NETs
By Will Morton
With a half-life of 3.3 hours, cyclotron-produced Cu-61 NODAGA-LM3 could allow delayed imaging and centralized distribution.
June 25, 2026
Maximum intensity projections showing biodistribution of Cu-61 NODAGA-LM3 (146 MBq) in a patient with a metastatic non-functional NET of the pancreas G2 (Ki-67: 5%) with lymph node, hepatic, osseous, and peritoneal as well as ovarian metastases. PET performed a 1-hour, 3-hours, and 18-hours post-injection show high and prolonged tumor uptake and excellent image contrast, with low uptake in the liver, intestinal tract, and other non-target organs.
Sectra signs enterprise imaging deal with German radiology group
By AuntMinnieEurope.com staff writers
Sectra has signed a 10-year enterprise imaging contract with MVZ MedDiagnost.
June 25, 2026
Sectra Rsna 2019 400
PET RANO gains visibility as neurotheranostics research advances
By Claudia Tschabuschnig
Standardized PET response assessment, emerging theranostic targets, and new strategies to overcome the blood-brain barrier are among the developments shaping neuro-oncology research.
June 24, 2026
Prof. Nathalie Albert of Ludwig Maximilian University of Munich, member of the EANM Oncology & Theranostics Committee and Scientific Chair of the NMN Symposium.
As theranostics advances, access challenges remain across Europe
By Claudia Tschabuschnig
Theranostics is advancing rapidly, but access remains uneven across Europe. According to Prof. Clemens Decristoforo, differences in national regulations and healthcare systems continue to influence patient access to innovative radiopharmaceuticals.
June 24, 2026
Prof. Clemens Decristoforo is a member of the EANM Policy & Regulatory Affairs Council and professor at the Department of Nuclear Medicine at the Medical University of Innsbruck.
BrightHeart receives CE mark for prenatal ultrasound AI platform
By AuntMinnieEurope.com staff writers
The CE mark follows an €11 million series A funding round.
June 24, 2026
Ai2